Tue, May 16, 2023

Oren Livnat Maintained (CARA) at Strong Buy with Decreased Target to $15 on, May 16th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-15-on-may-16th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Decreased Target from $20 to $15 on, May 16th, 2023.

Oren has made no other calls on CARA in the last 4 months.



There are 3 other peers that have a rating on CARA. Out of the 3 peers that are also analyzing CARA, 0 agree with Oren's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Oren


  • Daniel Wolle of "JP Morgan" Maintained at Buy with Decreased Target to $16 on, Tuesday, March 7th, 2023
  • David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 7th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023